1. Home
  2. ACCL vs ATNM Comparison

ACCL vs ATNM Comparison

Compare ACCL & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acco Group Holdings Limited Ordinary Shares

ACCL

Acco Group Holdings Limited Ordinary Shares

N/A

Current Price

$2.90

Market Cap

26.9M

ML Signal

N/A

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

N/A

Current Price

$1.08

Market Cap

31.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ACCL
ATNM
Founded
2009
2000
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.9M
31.7M
IPO Year
2024
2013

Fundamental Metrics

Financial Performance
Metric
ACCL
ATNM
Price
$2.90
$1.08
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
42.9K
165.1K
Earning Date
05-20-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.17
EPS
N/A
0.71
Revenue
N/A
$90,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.13
$1.48
Revenue Growth
N/A
11.11
52 Week Low
$1.23
$0.74
52 Week High
$5.00
$1.80

Technical Indicators

Market Signals
Indicator
ACCL
ATNM
Relative Strength Index (RSI) 78.01 63.58
Support Level $2.90 $0.94
Resistance Level $3.20 $1.11
Average True Range (ATR) 0.12 0.07
MACD -0.02 0.03
Stochastic Oscillator 60.70 82.61

Price Performance

Historical Comparison
ACCL
ATNM

About ACCL Acco Group Holdings Limited Ordinary Shares

Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

Share on Social Networks: